老虎證券

BRIEF-Infinity Pharmaceuticals Announces Termination Of Merger Agreement With MEI Pharma

Reuters
2023/07/24

July 24 (Reuters) - Infinity Pharmaceuticals Inc

:

* INFINITY PHARMACEUTICALS ANNOUNCES TERMINATION OF MERGER AGREEMENT WITH MEI PHARMA

* INFINITY PHARMACEUTICALS INC- EGANELISIB REMAINS PRIMARY VALUE DRIVER FOR INFINITY

* INFINITY PHARMACEUTICALS INC - INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS

* INFINITY PHARMACEUTICALS INC - INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS

* INFINITY PHARMACEUTICALS INC- INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS

* INFINITY PHARMACEUTICALS - COMPANY'S BOARD AND MANAGEMENT TEAM EXPECT TO UNDERTAKE A SERIES OF COST SAVING MEASURES

* INFINITY PHARMACEUTICALS INC- AS A RESULT OF TERMINATION OF MERGER AGREEMENT, INFINITY ENTITLED TO REIMBURSEMENT OF OF $1 MILLION FROM MEI

* INFINITY PHARMACEUTICALS INC - INFINITY HAS POTENTIAL TO RECEIVE AN ADDITIONAL $4 MILLION TERMINATION FEE FROM MEI UNDER CERTAIN CIRCUMSTANCES

* INFINITY PHARMACEUTICALS INC- COMPANY'S BOARD AND MANAGEMENT TEAM EXPECT TO UNDERTAKE A SERIES OF COST SAVING MEASURES

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10